{"id":6994,"date":"2011-07-11T08:00:08","date_gmt":"2011-07-11T05:00:08","guid":{"rendered":"http:\/\/wwwen.anm.ro\/?p=6994"},"modified":"2017-07-12T12:49:55","modified_gmt":"2017-07-12T09:49:55","slug":"anunt-important-11-07-2011","status":"publish","type":"post","link":"https:\/\/www.anm.ro\/en\/anunt-important-11-07-2011\/","title":{"rendered":"Important notification"},"content":{"rendered":"<p><strong>11.07.2011<\/strong><br \/>\n<span style=\"color: #333399;\"><b>To the attention of Marketing Authorisation Holders<\/b><\/span><br \/>\nGiven implementation of the new pharmacovigilance legislation, pharmaceutical companies need to add to the \u201cEudraVigilance Medicinal Product Dictionary\u201d, in electronic format, information about medicinal products authorised for marketing in the European Union (Romania included), starting with September 2011, via the EudraVigilance Gateway (in .XSD compliant format) or from January 2012, via a programme to be provided by the European Medicines Agency starting with that date.<br \/>\nThe process needs to be closed on 2 July 2012.<br \/>\nFor further information, please access (and keep updated with) the following links:<br \/>\n<a href=\"http:\/\/eudravigilance.ema.europa.eu\/Decommissioned\/Decommissioned.html\" target=\"_blank\" rel=\"noopener noreferrer\">http:\/\/eudravigilance.ema.europa.eu\/<\/a> <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><br \/>\n<a href=\"http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2011\/06\/news_detail_001293.jsp&#038;murl=menus\/news_and_events\/news_and_events.jsp&#038;mid=WC0b01ac058004d5c1\" target=\"_blank\" rel=\"noopener noreferrer\">http:\/\/www.ema.europa.eu\/<\/a> <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>11.07.2011 To the attention of Marketing Authorisation Holders Given implementation of the new pharmacovigilance legislation, pharmaceutical companies need to add [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"class_list":["post-6994","post","type-post","status-publish","format-standard","hentry","category-anunturi-importante-medicamente-de-uz-uman"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/posts\/6994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/comments?post=6994"}],"version-history":[{"count":0,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/posts\/6994\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/media?parent=6994"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/categories?post=6994"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/tags?post=6994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}